Predict your next investment

HiFiBiO Therapeutics company logo
Corporation
HEALTHCARE | Biotechnology
hifibio.com

See what CB Insights has to offer

Founded Year

2013

Stage

Series D | Alive

Total Raised

$179.5M

Last Raised

$75M | 2 mos ago

About HiFiBiO Therapeutics

HiFiBiO Therapeutics is a multinational biotherapeutics company mobilizing the human immune system to combat disease. The company integrates biological expertise with its single-cell profiling technologies to discover and advance a pipeline of antibody drugs to treat cancer and autoimmune disorders.

HiFiBiO Therapeutics Headquarter Location

29 Rue du Faubourg Saint-Jacques

Paris, 75014,

France

Latest HiFiBiO Therapeutics News

HiFiBiO Therapeutics Closes USD 75M Series D

Jun 24, 2021

HiFiBiO Therapeutics, a multinational biotechnology company with unique expertise in immune modulation and drug intelligent science, today announced the completion of an oversubscribed USD 75M Series D financing round. The funding was led by the new investor Mirae Asset Financial Group. Further, B Capital Group, Sherpa, Maison Capital, Trinity Innovation Fund, Grand Mount, and HKSTP Venture Fund also participated in this round.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing HiFiBiO Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

HiFiBiO Therapeutics is included in 5 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

S

Sequoia Capital China Investments 2018-2019

149 items

B

Biopharmaceuticals

5,731 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

C

Cancer

4,844 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

I

Infectious Disease

2,330 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

HiFiBiO Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

HiFiBiO Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.